10x Genomics, a leader in single cell and spatial genomics tools, reported a notable insider sale amid ongoing sector innovation.…
Image source: The Motley Fool.DATEThursday, May 7, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer and Co-Founder — Serge SaxonovChief…
10x Genomics (TXG) delivered earnings and revenue surprises of +65.52% and +3.57%, respectively, for the quarter ended March 2026. Do…
10x Genomics stock tumbles as ARK Invest dumps shares…
Image source: The Motley Fool.DATETuesday, Feb. 24, 2026 at 4:30 p.m. ETCALL PARTICIPANTSPresident and Chief Executive Officer — John HannaChief…
…
10x Genomics (TXG) delivered earnings and revenue surprises of +31.58% and +0.01%, respectively, for the quarter ended December 2025. Do…
…
10x Genomics stock hits 52-week high at 17.26 USD…
Das Life-Science-Technologieunternehmen erregte im Laufe der Woche als eine der wachstumsstärksten Aktien im Megatrend "E-Health" meine Aufmerksamkeit. Nachdem 10x gestern,…
Key PointsLancaster Investment Management bought over 620,000 shares in 10x Genomics (TXG) worth around $7.27 million.10x Genomics, a new holding…
10x Genomics stock rises after Anthropic AI partnership announcement…
Zacks spotlights five efficient stocks Red Robin, 10x Genomics, Norwegian Cruise Line, Electromed, and Analog Devices that excel in…
Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasnt been having it easy in the past few days on the…
10x Genomics (TXG) delivered earnings and revenue surprises of 20% and 16.24%, respectively, for the quarter ended March 2025. Do…
Long term investing works well, but it doesnt always work for each individual stock. We dont wish catastrophic...…
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, der führende Anbieter von zugänglicher und skalierbarer Einzelzellsequenzierung, bekräftigte heute seine Pläne, die Entwicklung und zukünftige Veröffentlichung…
…
10x Genomics (TXG) delivered earnings and revenue surprises of -25% and 0.03%, respectively, for the quarter ended December 2024. Do…
10X Genomics shares rise on Q4 sales beat…
Die 10X Genomics Aktie zeigt sich zum Handelsschluss am 08. Dezember 2024 unverändert bei 15,07 EUR. Das Biotech-Unternehmen, das sich…
Die 10X Genomics Aktie verzeichnete in den letzten Tagen einen deutlichen Kursrückgang. Trotz dieser negativen Entwicklung gibt es auch positive…
…
…
Per a preliminary report from 10x Genomics, the companys revenues will decline for the third quarter. Lower Instruments sales are…
Zacks Medical Info Systems industry stocks like Inspire Medical Systems, 10x Genomics and Omnicell are expected to gain from the…
Die Aktie von 10X Genomics verzeichnete am 26. Oktober 2024 einen leichten Anstieg von 0,13% auf 15,49 USD. Trotz dieses…
…
After-hours movers: 10x Genomics, AZZ, Inc., Applied Digital, and more…
…
…
10x Genomics launches enhanced single cell analysis products…